Regulus Therapeutics Inc.
(RGLS)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 23.77M | 24.23M | 60.38M | 31.09M | 34.12M | 13.94M | 13.52M | 76.11M | 115.32M | 37.33M | 114.00M | 40.55M | 9.18M |
| Short-Term Investments | - | 14.93M | - | - | - | - | 46.55M | 61.17M | 98.10M | 122.42M | 96.20M | 57.55M | 28.97M |
| Long-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Long-Term Assets | - | - | 291.00K | 277.00K | 487.00K | 326.00K | 590.00K | 342.00K | 344.00K | 1.81M | 987.00K | 125.00K | 125.00K |
| Receivables | - | - | - | 503.00K | 1.14M | 26.00K | 373.00K | 1.66M | 10.02M | 274.00K | 79.00K | - | - |
| Inventory | 3.01M | 3.01K | 3.01K | 3.31M | 3.92M | 4.19M | 4.78M | 5.55M | -10.02M | - | -79.00K | - | - |
| Other Current Assets | 1.40M | 1.91M | 1.84M | 1.83M | 5.14M | 5.33M | 3.01M | 4.15M | 10.17M | 4.93M | 3.10M | 1.66M | 522.00K |
| Total Current Assets | 28.18M | 44.08M | 65.23M | 36.73M | 40.41M | 19.30M | 66.74M | 87.47M | 134.26M | 164.95M | 117.18M | 98.93M | 38.67M |
| Property-Plant & Equipment | 2.54M | 2.58M | 2.85M | 472.00K | 921.00K | 7.81M | 9.71M | 11.83M | 5.40M | 3.57M | 3.77M | 3.31M | 3.11M |
| Goodwill & Intangibles | 33.00K | 62.00K | 83.00K | 125.00K | 266.00K | 500.00K | 775.00K | 1.01M | 1.08M | 1.15M | 1.13M | 1.15M | 980.00K |
| Total Long-Term Assets | 2.57M | 2.64M | 3.22M | 874.00K | 1.67M | 8.63M | 11.07M | 13.19M | 6.83M | 6.53M | 5.88M | 4.59M | 4.21M |
| Total Assets | 30.75M | 46.72M | 68.45M | 37.60M | 42.08M | 27.93M | 77.81M | 100.66M | 141.08M | 171.48M | 123.06M | 103.52M | 42.88M |
| Account Payables | 204.00K | 175.00K | 285.00K | 535.00K | 1.32M | 1.71M | 5.74M | 5.84M | 2.72M | 2.19M | 1.17M | 311.00K | 501.00K |
| Deferred Revenue | - | - | -589.00K | 3.42M | 6.00K | 2.57M | 72.00K | 72.00K | 1.19M | 3.10M | 4.89M | 10.45M | 10.73M |
| Short-Term Debt | 1.33M | 4.51M | - | 4.65M | 14.63M | 16.57M | 19.86M | - | - | 23.40M | - | - | 377.00K |
| Other Current Liabilities | 6.97M | 6.97M | 4.94M | 6.39M | 5.64M | 5.79M | 6.93M | 7.89M | 8.72M | 6.51M | 4.31M | 2.01M | 1.03M |
| Total Current Liabilities | 8.51M | 11.66M | 5.23M | 11.58M | 21.60M | 26.65M | 32.60M | 13.73M | 11.44M | 8.70M | 5.48M | 12.77M | 12.85M |
| Long-Term Debt | 1.05M | 1.77M | 7.09M | - | - | - | - | 19.80M | - | - | 11.28M | 10.13M | 10.44M |
| Other Long-Term Liabilities | - | - | 1.18M | - | 468.00K | 7.13M | 8.07M | 10.98M | 2.31M | 1.02M | 1.46M | 767.00K | 44.10M |
| Total Long-Term Liabilities | 1.05M | 1.77M | 8.27M | - | 468.00K | 7.13M | 9.99M | 30.85M | 5.57M | 30.77M | 24.13M | 28.66M | 71.53M |
| Total Liabilities | 9.56M | 13.43M | 13.50M | 11.58M | 22.07M | 33.78M | 42.59M | 44.59M | 17.00M | 39.47M | 29.61M | 41.42M | 84.38M |
| Total Debt | 2.39M | 6.28M | 7.09M | 4.65M | 14.63M | 16.57M | 19.86M | 19.80M | - | 23.40M | 11.28M | 10.13M | 10.81M |
| Common Stock | 20.00K | 17.00K | 146.00K | 67.00K | 21.00K | 9.00K | 104.00K | 53.00K | 53.00K | 49.00K | 42.00K | 36.00K | - |
| Retained Earnings | -513.21M | -483.18M | -454.85M | -427.05M | -411.31M | -392.72M | -345.86M | -273.35M | -191.51M | -135.77M | -79.09M | -60.42M | -43.01M |
| Comprehensive Income | - | -12.00K | - | - | - | -9.89M | -134.00K | -123.00K | -133.00K | -197.00K | -16.00K | -52.00K | -67.00K |
| Shareholders Equity | 21.19M | 33.29M | 54.96M | 26.03M | 20.02M | -5.85M | 35.22M | 56.08M | 124.08M | 132.01M | 93.46M | 62.09M | -41.49M |
| Total Investments | - | 14.93M | - | - | - | - | 46.55M | 61.17M | 98.10M | 122.42M | 96.20M | 57.55M | 28.97M |